![](https://entrepreneurs.utoronto.ca/wp-content/uploads/2023/06/B-celera.png)
B-Celera
B-celera has innovated a technology that provides a novel route of aspirin administration through direct systemic absorption on the inner cheek (buccal administration) in two forms (rapid or slow-release).
B-celera has innovated a technology that provides a novel route of aspirin administration through direct systemic absorption on the inner cheek (buccal administration) in two forms (rapid or slow-release).